SABS
SAB Biotherapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD3.36
-0.12 (-3.45%)
Rating:C+
Company Profile
CEO
Samuel J. Reich
IPO Date
2021-02-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$3.47
Prev. Close
$3.48
Day Low
$3.32
Day High
$3.49
52W Low
$1.60
52W High
$6.60
Market Cap
$0.03B
Volume
0.33M